AmerisourceBergen Corp. (NYSE: ABC) was maintained as Buy but the price target was lowered to $100 from $120 (versus a $78.56 close) at Argus.
China Telecom Corp. Ltd. (NYSE: CHA) was reinstated as Buy with a $63.23 equivalent American depositary share (ADS) price objective (versus a $50.52 close) at Merrill Lynch, with the firm noting better dividend clarity than peers. The ADSs have a 52-week trading range of $45.58 to $53.61.
Dominion Midstream Partners L.P. (NYSE: DM) was raised to Overweight from Equal Weight with a $32 price target (versus a $27.70 close) at Morgan Stanley.
Everbridge Inc. (NASDAQ: EVBG) was started with an Outperform rating and assigned a $28 price target (versus a $22.55 close) at Northland Securities.
GlaxoSmithKline PLC (NYSE: GSK) was maintained as Buy with a $50 ADS target (versus a $39.32 close) at Argus, with the firm noting that the recent weakness offers a buying opportunity.
Hess Midstream Partners L.P. (NYSE: HESM) was raised to Overweight from Equal Weight with a $24 price target (versus a $19.69 close) at Morgan Stanley.
La Jolla Pharmaceutical Co. (NASDAQ: LJPC) was started with an Overweight rating and assigned a $36 price target (versus a $34.31 close) at JPMorgan.
Patterson-UTI Energy Inc. (NASDAQ: PTEN) was raised to Buy from Neutral and the price target was raised to $21 from $19 (versus a $15.689 close) at Citigroup.
Prospect Capital Corp. (NASDAQ: PSEC) was raised to Market Perform from Underperform at Raymond James.
Reata Pharmaceuticals Inc. (NASDAQ: RETA) was started with a Buy rating and was given a $44 price target (versus a $27.84 close) at Jefferies. The firm noted the positive Alport data and that Bardoxolone is hitting its stride.
Roper Technologies Inc. (NYSE: ROP) was reiterated as Buy with a $260 price target (versus a $229.47 close) at Argus.
Sanofi S.A. (NYSE: SNY) was raised to Hold from Reduce at HSBC.
Santander Consumer USA Holdings Inc. (NYSE: SC) was raised to Overweight Neutral with a $17 price target at Piper Jaffray.
Vornado Realty Trust (NYSE: VNO) was downgraded to Hold from Buy at Stifel.
Tuesday’s top analyst upgrades and downgrades included Amphenol, Finish Line, Jack Henry, Kite Pharmaceutical, Ultra Petroleum and many more.